1. 日本老年医学会編:高齢者の安全な薬物療法ガイドライン2015,日本医療研究開発機構,東京. 2015, pp8 - 12 .
2. 前田健次;多剤服用高齢者における薬物療法の適正化による服用薬剤数の減少効果に関する系統的文献レビュー,YAKUGAKU ZASSHI , 2009, 129 , 631 - 645 .
3. 佐藤武,佐藤和典,佐藤暁;回復期リハビリテーション病棟における服薬数減量の取り組み,日本老年医学会雑誌,2010,47 , 440 - 444.
4. A l e s s a n d r o N , A l e s s a n d r a M , M a u r o T, F r a n c e s c o S , L u c a P, C a r l o t t a F, A , M a u r a M , S a l v a t o r e C , G i u s e p p e L , P i e r M . A s s o c i a t i o n b e t w e e n c l u s t e r s o f d i s e a s e s a n d p o l y p h a r m a c y i n h o s p i t a l i z e d e l d e r l y p a t i e n t s : R e s u l t s f r o m t h e R E P O S I s t u d y , Eur J Intern Med . 2011 ; 22 ( 6 ) : 597 - 602 .
5. 日本糖尿病学会編.糖尿病診療ガイドライン2016,南江堂,東京. 2016, pp473 - 48.
6. Robert C. T, Valeria F. for the UK Prospecti ve Diabetes S tudy ( U KPDS) Group. Glycemic Control With Diet, Sulfonylurea, Metformin, or Insulin in Patients With Type 2 Diabetes Mellitus P rogressive Requirement for Multiple Therapies ( UKPDS 49 ) , JAMA. 1999 ; 281 ( 21 ) : 2005 - 20 12 .
7. 堀井剛史,壁谷悠介,富田益臣,香月健志,及川洋一,清水淳一,島田朗.メトホルミン,シタグリプチンの単剤における治療継続性と有効性の比較, J Pharmaceutic Diabetes . , 2015 , 4 ( 2 ) , 189 - 1 96.
8. 山﨑勝也,戸邉一之,小林正.糖尿病予防のための戦略研究: J- DOIT 2 . Diabetes Frontier, 2008 , 19 : 643 - 646
9. 野田光彦.糖尿病の戦略研究J-DOIT2―経過と結果の概要, 2014,糖尿病57 : S- 81 .
10. 野田光彦,山崎勝也,林野泰明,泉和生,後藤温.糖尿病受診中断対策包括ガイド, 2014. http: ncg m- dm. jprenkeibudm_jushinchudan_guide. pdf
11. 日本糖尿病学会編. 糖尿病診療ガイドライン2016, 南江堂, 東京. 2016 , pp 411 - 448
12. 日本糖尿病学会編:糖尿病診療ガイドライン2016, 南江堂, 東京. 2016, pp 195 - 220
13. Sussman JB, Kerr EA, Saini SD, Holleman RG, Klamerus ML, Min LC, Vijan S, Hofer TP. Rates of deintensification of b lood pressure and g lycemic medication t reatment based on levels of control and l i fe expectancy in older patients with diabetes mellitus. JAMA Intern Med . 2015, 175( 12 ) , 1942 - 9.
14. Duerden M, Tony A, Rupert P. Polypharm acy and medicines optimization making i t safe and sound. The Kings Fund , 2013 , pp 1 - 4.
15. 日本老年医学会編.高齢者の安全な薬物療法ガイドライン2015, 日本医療研究開発機構, 東京.2015, 1項pp 2 - 12 .
16. 寶滿誠,松田晋哉. 福岡県の某健康保健組合における老人保健制度医療対象レセプトの解析:外来診療における個人単位分析,多科・重複受診に関するレセプト解析,日本公衆衛生雑誌, 2001 , 48 , 551 - 9.
17. Osamu I imura. Insulin Resistance and Hypertension in Japanese. Hypertens Res , 1996, 19 , 1 - 8.
18. Henry P, Thomas F, Benetos A , Guize L. Impaired fasting g lucose, b lood pressure and cardiovascular disease mortality. Hypertension , 2002 , 40 ( 4 ) , 458 - 63 .
19. Pechère- Bertschi A , Greminger P, Hess L, Philippe J , Ferrari P. Swiss Hypertension and Risk Factor Program ( S HARP). Cardiovascular r i sk factors management in patients with type 2 d iabetes in Switzerland, Blood Press , 2005, 14 ( 6 ) , 337 - 44.
20. NIPPON DATA 80 Research Group . Risk Assessment Chart for Death F rom Cardiovascular D i sease Based on a 19 - Year Follow - up Study of a Japanese Representative Population NIPPON DATA 80 , Circ J , 2006 , 70 ( 10 ) , 1249 - 1255.
21. Asia Pacific Cohort Studies Collaboration , K engne AP, Patel A , Barzi F, Jamrozik K, Lam TH, Ueshima H , Gu DF, Suh I , Woodward M. Systolic blood pressure, diabetes and the r i sk of cardiovascular d i seases in the Asia - Pacific region, J Hypertens . 2007, 25 ( 6 ) : 1205 - 13 .
22. American Diabetes Association . Microvascular Complications and Foot Care, Diabetes Care 2017 , 40 ( Supplement 1 ), S88 - S98.
23. American Diabetes Association. Diabetes and Hypertension . A Position Statement by the American Diabetes Association Diabetes Care 2017 , 40 ( 9 ) , 1273 - 1284.
24. Heart Outcomes Prevention Evaluation Study Investigators. Effects of ramipril on cardiovascular and microvascular outcomes in people with d iabetes mellitus: results of the HOPE s tudy and MICRO - HOPE substudy. Lancet , 2000 , 2 , 356 ( 9232 ) , 860 .
25. Lewis JB, Berl T, Bain R P, Rohde RD, Lewis EJ. Effect of intensive blood pressure control on the course of type 1 diabetic nephropathy. Collaborative Study Group. Am J Kidney Dis . 1999, 34 ( 5 ) : 809 - 17.
26. Jamerson K , Weber MA , Bakris GL , Dahlöf B , Pitt B, Shi V, Hester A , Gupte J , Gatlin M, Velazquez EJ, ACCOMPLISH Trial Investigators . Benazepril plus amlodipine or hydrochlorothiazide for hypertension in h igh - r i sk patients, N Engl J Med . 2008 , 4, 359 ( 23 ) , 2417 - 28.
27. Sone H, Tanaka S, Tanaka S, I imuro S, Oida K, Yamasaki Y, Oikawa S, Ishibashi S, Katayama S, Ohashi Y, Akanuma Y, Yamada N . Japan Diabetes Complications Study Group. Serum l evel of t r iglycerides i s a potent r i sk factor comparable to LDL cholesterol for coronary heart d i sease in Japanese patients with type 2 diabetes: subanalysis of the Japan Diabetes Complications Study ( JDCS). J Clin Endocrinol Metab , 20 11 , 96( 11 ) , 3448 - 56.
28. Costa J , Borges M, D avid C, Vaz Carneiro A. Efficacy of l ip id lowering drug t reatment for diabetic and non - diabetic patients: meta - analysis of randomized controlled t r ials. BMJ . 2006; 332 ( 7550 ) : 1115 - 24.
29. 金井紀仁,宮下紗季,赤沢学.2型糖尿病患者に対する10年間の処方推移(会議録),日本薬学会年会要旨集, 2016, 4 , 99 .
30. Yoda K, Inaba M, Hamamoto K , Yoda M, Tsuda A, Mori K, Imanishi Y, Emoto M, Yamada S. Association between Poor Glycemic Control, Impaired S leep Quality, and Increased Arterial Thickening in Type 2 Diabetic Patients , PLos One, 2015, 10 ( 4 ) .
31. 赤尾綾子,郡山暢之,安楽千鶴,三反陽子,尾辻真由美,前田円佳,森加弥,渡辺あつ子,河本美津紀,深川俊子.2型糖尿病患者の睡眠・排尿・末梢神経障害に関する実態調査—アンケート調査により浮かび上がった特徴—,糖尿病, 2008 , 51 ( 11 ) , 1025 - 1030.
32. Araki A , I to H. Diabetes mellitus and geriatric syndromes, Geriatr Gerontol Int , 2009, 9( 2 ) , 105 - 14.
33. 石崎高志.加齢に伴う生理機能の変化と薬物動態・薬力学的反応の変化 , JIM , 2003 , 13 ( 11 ) , 914 - 920.
34. UK Prospective Diabetes Study Group. Tight blood pressure control and r i sk of macrovascular and microvascular complications in ty pe 2 d iabetes: UKPDS 38 , BMJ , 1998, 317 ( 7160 ) , 703 - 13 .
35. de Galan BE , Perkovic V, Ninomiya T, Pillai A , Patel A , Cass A , Neal B, Poulter N, Harrap S, Mogensen CE , Cooper M, Marre M, Williams B , Hamet P, Mancia G, Woodward M, Glasziou P, Grobbee DE , Mac Mahon S, Chalmers J . ADVANCE Collaborative Group ; Lowering blood pressure reduces renal events in type 2 diabetes. J Am Soc Nephrol , 2009, 20 ( 4 ) , 88 3 - 92 .
36. Colhoun HM, Betteridge DJ , Durrington PN , Hitman GA, Neil HA , Livingstone SJ, Charlton - Menys V, De Micco DA , Fuller JH ; CARDS Investigators . Effects of atorvastatin on kidney outcomes and cardiovascular d i sease in patients with diabetes: an analysis f rom the Collaborative Atorvastatin Diabetes S tudy ( CARDS), Am J Kidney Dis , 2009, 54( 5 ) : 810 - 9.
37. Moriya T, Tanaka S, Kawasaki R , Ohashi Y, Akanuma Y, Yamada N , Sone H, Yamashita H , Katayama S ; Japan Diabetes C omplications Study Group . Diabetic retinopathy and microalbuminuria can predict macroalbuminuria and renal function decline in Japanese type 2 diabetic patients: Japan Diabetes Complications Study, Diabetes Care , 2013 , 36 ( 9 ) , 2803 - 9.
38. I r ie F, I so H, Sairenchi T, Fukasawa N , Yamagishi K , Ikehara S , Kanashiki M, Saito Y, Ota H , Nose T. The re lat ionships of proteinur ia , serum creatinine, glomerular f i l t ra t ion rate with cardiovascular disease mortality in Japanese general population, Kidney Int , 2006 , 69 ( 7 ) , 1264 - 71 .
39. Bangalore S, Kamalakkannan G , Parkar S, Messerli FH . Fixed- dose combinations improve medication compliance : a meta- analysis, Am J Med , 2007 , 120 ( 8 ) , 713 - 9.
40. A l e s s a n d r o N , A l e s s a n d r a M , M a u r o T, F r a n c e s c o S , L u c a P, C a r l o t t a F, A , M a u r a M , S a l v a t o r e C , G i u s e p p e L , P i e r M . A s s o c i a t i o n b e t w e e n c l u s t e r s o f d i s e a s e s a n d p o l y p h a r m a c y i n h o s p i t a l i z e d e l d e r l y p a t i e n t s : R e s u l t s f r o m t h e R E P O S I s t u d y , Eur J Intern Med . 2011 ; 22 ( 6 ) : 597 - 602 .
41. Boyd CM, Darer J , Boult C, Fried L P, Boult L, Wu AW. Clinical practice guidelines and quality of care for o lder patients with multiple comorbid diseases: implications for pay for performance. JAMA . 2005; 294 ( 6 ) : 716 - 24.
42. Hajjar ER, Cafiero AC, Hanlon JT. Polypharmacy in e lderly patients. Am J Geriatr Pharmacother . 2007 ; 5 ( 4 ) : 345 - 51 .
43. Dumbreck S, Flynn A, Nairn M, Wilson M, Treweek S, Mercer SW, Alderson P, Thompson A, Payne K, Guthrie B. Drug - d i sease and drug - drug in te ractions: systematic examination of recommendations in 12 UK national cl in ical guidelines. BMJ . 2015; 350 : h 949 .
44. Hikaru K, Hitoshi K, Setsuko I . The r i sk of adverse reaction in elderly patients undergoing polypharmacy. J Pharm Health Care Sci . 2003 ; 29 : 100 - 106. Campbell SE, Seymour DG, Primrose WR. A systematic l i terature review of factors affecting outcome in o lder medical patients admitted to hospital. Age Ageing. 2004 ; 33 : 110 - 115.
45. Espino DV, Bazaldua OV, Palmer RF, Mouton C P, Parchman ML, Miles T P, Markides K. Suboptimal medication use and mortality in an older adult community- based cohort: results f rom the Hispanic EPESE Study. J Gerontol A Biol Sci Med Sci . 2006 ; 61 ( 2 ): 170 - 5.
46. Masoudi FA, Baillie C A, Wang Y, Bradford WD, Steiner JF, Havranek E P, Foody JM, Krumholz HM. The complexity and cost of drug regimens of older patients hospitalized with heart fa i lure in the United States, 1998 - 2001 . Arch Intern Med . 2005; 165 ( 18 ) : 2069 - 76.
47. Cahir C, Fahey T, Teeling M, Teljeur C, Feely J, Bennett K. Potentially inappropriate prescribing and cost outcomes for o lder people: a national population s tudy. Br J Clin Pharmacol . 2010 ; 69 ( 5 ) : 543 - 52 .
48. Horii T, Kabeya Y, Shimizu J , Tomita M . Study on r i sk of po lypharmacy caused by diabetes. J Pharmaceutic Diabetes . 2017 ; 6 : 179 - 187.
49. Peterson JF, Kuperman GJ, Shek C, Patel M, Avorn J , Bates DW. Guided prescription of psychotropic medications for geriatric inpatients. Arch Intern Med . 2005; 165 ( 7 ) : 802 - 7.
50. Ruhland DJ, Bellone JM, Wilkes E. Implementation and assessment of an ambulatory prescribing guidance tool to improve patient safety in the geriatric population. Consult Pharm. 2017; 32 : 169 - 1 74.
51. Mattison ML, Afonso KA, Ngo LH, Mukamal KJ. Preventing potentially inappropria te medication use in hospitalized older patients with a computerized provider order entry warning system. Arch Intern Med . 2010; 170( 1 5 ) : 1331 - 6.
52. Lester PE, Rios - Rojas L, Islam S, Fazzari MJ, Gomolin IH. Impact of computerized physician order entry a ler t s on prescribing in o lder patients. Drugs Aging . 2015; 32 ( 3 ): 227 - 33 .
53. Ministry of Health, Labour and Welter Japan, Estimates of National Medical Care Expenditure ( 201 8).
54. Wang HY, Chan AL, Chen MT, Liao CH, Tian YF. Effects of pharmaceutical care in tervention by cl inical pharmacists in renal t ransplant c l inics. Transplant Proc . 2008 ; 40 ( 7 ) : 2319 - 23 .
55. American Geriatrics S ociety 2012 Beers Criteria Update Expert Panel. American Geriatrics S ociety updated Beers Criteria for potentially inappropriate medication use in o lder adults. J Am Geriatr Soc . 2012 ; 60 ( 4 ) : 616 - 31 .
56. O' Mahony D, O' Sullivan D, Byrne S, O' Connor MN, Ryan C, Gallagher P. STOPP/ START criteria for potentially inappropriate prescribing in older people: version 2 . Age Ageing . 2015 ; 44 ( 2 ): 213 - 8.
57. Kojima T, Mizukami K, Tomita N, Arai H, Ohrui T, Eto M, Takeya Y, Isaka Y, Rakugi H, Sudo N, Arai H, Aoki H, Horie S, Ishii S, Iwasak i K, Takayama S, Suzuki Y, Matsui T, Mizokami F, Furuta K, Toba K, Akishita M; Working Group on Guidelines for Medical Treatment and i t s Safety in the E lderly. Screening Tool for Older Persons' Appropriate Prescriptions for Japanese: R eport of the Japan Geriatrics Society Working Group on " Guidelines for medical t reatment and i t s safety in the elderly". Geriatr Gerontol Int . 2016; 16 ( 9 ) : 98 3 - 1001 . Hamano J , Tokuda Y. Inappropriate prescribing among elderly home care patients in Japan: prevalence and r i sk factors. J Prim Care Community Health 2014 ; 5 : 90 - 96.
58. Hamano J , Ozone S, Tokuda Y. A comparison of estimated drug costs of potentially inappropriate medications b e tween older patients receiving nurse home visit services and patients receiving pharmacist home visit services: a cross- sectional and propensity score analysis. BMC Health Serv Res . 2015 ; 15 : 1 - 9.
59. Fumie Ogura, Takeshi Kimura, Atsushi Uda, Asuka Toda, Yuko Akazawa, Kazuhiro Yamamoto, Takeshi Ioroi, Tatsuya Nishioka, Manabu Kume, Hiroo Makimoto, Midori Hirai. Pharmaceut ical Intervention to Manage Polypharmacy in Elderly Patients based on S TOPP Criteria. Iryo yakugaku . 2016 ; 42 : 78 - 86.
60. Pyszka LL, Seys Ranola TM, Milhans SM. Identification of inappropriate prescribing in geriatrics at a Veterans Affairs hospital using STOP P/ START screening tools. Consult Pharm . 2010 ; 25 : 365 - 373 .
61. Liu CL, Peng LN, Chen YT, Lin MH, Liu LK, Chen LK. Potentially inappropriate prescribing ( IP ) for elderly medical inpatients in Taiwan: a hospital- based s tudy. Arch Gerontol Geriatr . 2012 ; 55( 1 ): 148 - 51 .
62. Ministry of Health, Labour and Welter Japan, https:// www. mhlw. go. jp/ f i le/ 05 - Shingikai- 12404000 - H okenkyoku- I ryouka/ 0000 188847.pdf. ( 2019, 12 , 10, 参照)
63. Miller, N. H. Compliance with t reatment regimens in chronic asymptomatic diseases. Am. J . Med. 1 997, 102 , 43 – 49.
64. Iglay K, Cartier SE, Rosen VM, Zarotsky V, Rajpathak SN, Radican L, Tunceli K. Meta- analysis of s tudies examining medication adherence, persistence, and discontinuation of oral antihyperglycemic agents in type 2 d iabetes. Curr Med Res Opin . 2015; 31 ( 7 ) : 1283 - 96.
65. Fukuda H, Mizobe M. Impact of nonadherence on complication r i sks and healthcare costs in patients newly - d iagnosed with diabetes. Diabetes Res Clin Pract . 2017; 123 : 55 - 62 .
66. Krass I , Schieback P, Dhippayom T. Adherence to d iabetes medication: a systematic review. Diabet Med . 2015; 32 ( 6 ) : 725 - 37. Kimura S, Sato T, Ikeda S, Noda M, Nakayama T. Development of a database of health insurance claims: s tandardization of disease classifications and anonymous record l inkage. J Epidemiol . 201 0; 20 ( 5 ) : 413 - 9.
67. Nakaoka S, Ishizaki T, Urushihara H, Satoh T, Ikeda S, Morikawa K, Nakayama T. Echocardiography for the detection of valvulopathy associated with the use of ergot- derived dopamine agonists in patients with Parkinson' s disease. Intern Med . 2011 ; 50 ( 7 ) : 687 - 94.
68. Kojima T, Akishita M, Kameyama Y, Yamaguchi K, Yamamoto H, Eto M, Ouchi Y. High r i sk of adverse drug reactions in elderly patients taking s ix or more drugs: analysis of inpatient database. Geriatr Gerontol Int . 2012 ; 12 ( 4 ) : 761 - 2 .
69. 日本糖尿病学会編:糖尿病診療ガイドライン2019,南江堂,東京. 2019 , pp 21 - 28.
70. Raum E, Krämer HU, Rüter G, Rothenbacher D, Rosemann T, Szecsenyi J , Brenner H. Medication non - adherence and poor glycaemic control in patients with type 2 d iabetes mellitus. Diabetes Res Clin Pract . 2012 ; 97 ( 3 ): 377 - 84.
71. ADVANCE Collaborative Group, Patel A, Mac Mahon S, Chalmers J , Neal B, Billot L, Woodward M, Marre M, Cooper M, Glasziou P, Grobbee D, Hamet P, Harrap S, Heller S, Liu L, Mancia G, Mogensen CE, Pan C, Poulter N, Rodgers A, Williams B, Bompoint S, de Galan B E, Joshi R, Travert F. Intensive blood glucose control and vascular outcomes in patients with type 2 d i abetes. N Engl J Med . 2008; 358( 24 ) : 2 560 - 72 .
72. Jamous RM, Sweileh WM, Abu - Taha AS, Sawalha AF, Zyoud SH, Morisky DE. Adherence and satisfaction with oral hy poglycemic medications: a pilot s tudy in Palestine. Int J Clin Pharm . 2011 ; 33 ( 6 ) : 942 - 8.
73. Kreyenbuhl J , Dixon LB, Mc Carthy JF, Soliman S, Ignacio RV, Valenstein M. Does adherence to medications for type 2 diabetes differ between individuals with vs without schizophrenia? Schizophr Bull . 2010; 36( 2 ) : 428 - 35.
74. Ahmad NS, Ramli A, Islahudin F, Paraidathathu T. Medication adherence in patients with type 2 diabetes mellitus t reated at primary health c l in ics in Malaysia. Patient Prefer Adherence . 2013 ; 7 : 525 - 30.
75. Curkendall SM, Thomas N, Bell KF, Juneau PL, Weiss AJ. Predictors of medication adherence in patients with type 2 diabetes mellitus. Curr Med Res Opin . 2013 ; 29( 10 ) : 1275 - 86.
76. Hertz R P, Unger AN, Lustik MB. Adherence with pharmacotherapy for type 2 diabetes: a re t rospective cohort s tudy of adults with employer - sponsored health insurance. Clin Ther . 2005; 27 ( 7 ) : 1064 - 73 .
77. Donnan PT, Mac Donald TM, Morris AD. Adherence to prescribed oral hypoglycaemic medication in a population of patients with Type 2 d iabetes: a retrospective cohort s tudy. Diabet Med . 2002 ; 19 ( 4 ) : 279 - 84.
78. 李廷秀,川久保清,川村勇人,平尾紘一.2型糖尿病患者における通院中断に関連する心理社会的要因.糖尿病. 2002; 46: 341-346.
79. 本田佳子,上月正博,村勢敏郎,佐藤徳太郎.2型糖尿病患者における教育入院後の外来通院状況.糖尿病.2004;47:355-361.
80. 横田友紀,菅野咲子,多田純子,石村郁恵,山下りさ,奥田昌恵,横山宏樹.糖尿病外来における通院中断例にみられる意識の調査.糖尿病; 2007, 50:883-886.
81. Tiv M, Viel JF, Mauny F, Eschwège E, Weill A, Fournier C, Fagot – Campagna A, Penfornis A. Medication adherence in type 2 diabetes: the ENTRED s tudy 2007, a French Population- Based Study. PLo S One . 2012 ; 7 ( 3 ) : e 324 12 .